WAYNE, PA — In a significant move that consolidates its position in the global medical technology solutions arena, TekniPlex Healthcare has signed a definitive agreement to acquire Seisa Medical. This acquisition will substantially augment TekniPlex’s materials science and process technologies for minimally invasive and interventional therapy devices.
El Paso-based Seisa Medical is known for its expertise in every stage of the medical device product life cycle, including design, development, component manufacturing, and final assembly. It employs over 2,000 individuals across facilities in the U.S., Mexico, and Slovakia, bringing a wealth of experience and talent into TekniPlex Healthcare’s fold.
“This is a transformative acquisition for TekniPlex Healthcare, moving us squarely into the contract, development, and manufacturing organization (CDMO) segment of MedTech for medical technologies,” said Chris Qualters, CEO of TekniPlex Healthcare. He further emphasized the strategic advantage of this acquisition, stating, “The ability for us to engage with our global customers on new medical technologies by developing engineered materials, co-designing components and assemblies, utilizing advanced process technologies and providing sterile barrier products allows us to truly partner with them from concept all the way to the point of care to help improve patient outcomes.”
Bryan Wesselmann, Vice President of Sales and Marketing for TekniPlex Healthcare, highlighted the rapidly evolving landscape of medical technologies. “Seisa brings broad capabilities to advance these interventional technologies such as abdominal aortic aneurysms stent grafts, thoracic endovascular grafts, mitral heart valves, endovascular procedures, and cardiovascular catheter delivery systems.”
Julio Chiu, Seisa founder and CEO, expressed confidence in the future of the combined entity. He said, “Our customers count on us to deliver solutions for their most challenging applications. I am very confident that they will continue to count on us as TekniPlex Healthcare shares our same commitment to deliver better patient outcomes. We believe the combination of our two organizations will result in one of the most comprehensive value-added CDMO platforms in the industry.”
This acquisition marks the 20th that TekniPlex has completed in the past decade, underscoring its strategy to expand its business through transformative acquisitions and strategic add-ons. The closing of the acquisition is conditioned upon regulatory approval, and once completed, it promises to greatly enhance TekniPlex Healthcare’s technology solutions platform in the minimally invasive and interventional therapies sector.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.